Stay updated on MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial

Sign up to get notified when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The old and new screenshots show minor UI/layout adjustments on the Record History page, while the version list and navigation remain unchanged. There is no change to core study data, status, or substantive content.
    Difference
    0.1%
    Check dated 2025-11-03T21:33:23.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    10%
    Check dated 2025-10-06T07:16:24.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-29T03:47:03.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2, and the Back to Top link was removed. No substantive updates to core content or pricing.
    Difference
    0.6%
    Check dated 2025-09-14T21:36:41.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.6%
    Check dated 2025-09-07T17:40:59.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    39%
    Check dated 2025-08-31T12:21:24.000Z thumbnail image

Stay in the know with updates to MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.